Agiron F (200 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Agrawal Pharmaceuticals. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Folic Acid (Vit B9), Cyanocobalamin,Ferric Ammonium Citrate. This drug comes in the form of Syrup. The general packing available for this medicine consists of 200 ml and is priced at Rs 63 (arround $0.882 US Dollar)
The main active ingredients or salts in Agiron F (200 ml) are :
Folic Acid (Vit B9)-1.5 mg
Cyanocobalamin-15 mcg
Ferric Ammonium Citrate-110 mg
Folic Acid (Vit B9) Indication (Prescribed for or used as): Folate-deficient. Megaloblastic anaemia. Prophylaxis of megaloblastic anemia in pregnancy. Prophylaxis of neural tube defect in pregnancy. Malabsorption syndromes. Antiepileptic therapy.
For more details on Folic Acid (Vit B9), its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Folic Acid (Vit B9)..
Cyanocobalamin Indication (Prescribed for or used as): in the treatment of megaloblastosis
For more details on Cyanocobalamin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cyanocobalamin..
Ferric Ammonium Citrate Indication (Prescribed for or used as):
For more details on Ferric Ammonium Citrate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ferric Ammonium Citrate..
Agiron F (200 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 1 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Agiron F (200 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Folic Acid (Vit B9)-1.5 mg Cyanocobalamin-15 mcg Ferric Ammonium Citrate-110 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.